MAIA Biotechnology MAIA
NYSE MAIA
$1.14 +0.01 (+0.88%)
As of: Oct 23, 2026 · 3:59 PM EDT

MAIA Biotechnology (MAIA) Return on Capital Employed [ROCE] (2022 - 2026)

Updated

MAIA Biotechnology (MAIA) recorded Return on Capital Employed [ROCE] of -113.41% in Q2 2026, up 195.18 percentage points from -308.59% a year earlier and up 45.90 percentage points from the prior quarter.

Analysis

MAIA Biotechnology (MAIA) Return on Capital Employed [ROCE] (2022 - 2026) Analysis & Trends

For FY2025, MAIA Biotechnology reported Return on Capital Employed [ROCE] of -592.87%, down 255.82 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a three-year change of -400.43 percentage points (FY2022 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -337.05% in FY2024 (+78.45 pp), -415.51% in FY2023 (-223.06 pp) and -192.44% in FY2022.
  • The Q2 2026 figure is the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] rose in five of the last eight quarters, with an average year-over-year change of -46.10 percentage points.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 571.06 percentage points in Q4 2024, against a drop of 1497.13 percentage points in Q3 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -159.31% (Q1 2026), -494.60% (Q4 2025) and -1758.16% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.52%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 16.76%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.86%
10 MAIA Biotechnology 69.78 Mn -11.78 Mn - -113.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -113.41%
Mar 31, 2026 -159.31%
Dec 31, 2025 -494.60%
Sep 30, 2025 -1,758.16%
Jun 30, 2025 -308.59%
Mar 31, 2025 -309.68%
Dec 31, 2024 -288.93%
Sep 30, 2024 -261.03%
Jun 30, 2024 -278.52%
Mar 31, 2024 -616.85%
Dec 31, 2023 -859.99%
Sep 30, 2023 -401.33%
Jun 30, 2023 -283.49%
Mar 31, 2023 -249.45%
Dec 31, 2022 -159.63%
Sep 30, 2022 -152.63%
API Access

MAIA Biotechnology Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=MAIA&period=max&api_key=YOUR_API_KEY